Perivascular delivery of rapamycin in pluronic gel inhibits neointimal hyperplasia in a rat carotid artery injury model, and the complementary role of carotid arteriography

Korean Circulation Journal

Volumn 38, Issue 2, 2008, Pages 80-86

  Jung, Mi Jin ^a   Kwon, Jin Sook ^b   Park, No Kwan ^c   Kim, Yu Kyung ^c   Tae, Jin Shim ^c   Il, Ha Jeong ^c   Bae, Jang Whan ^c   Hwang, Kyung Kuk ^c   Kim, Dong Woon ^c   Cho, Myeong Chan ^c  

^a Gachon University College of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

Author keywords

Angiography; Drug delivery system; Rapamycin; Restenosis

Indexed keywords

RAPAMYCIN; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; BYPASS SURGERY; CARDIOVASCULAR SYSTEM; CAROTID ARTERIOGRAPHY; CAROTID ARTERY; CAROTID ARTERY INJURY; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DNA SYNTHESIS; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG INHIBITION; DRUG RELEASE; GEL; INTIMA; KINETICS; MALE; MORPHOMETRICS; NONHUMAN; RAT; RESTENOSIS; TIME; VASCULAR SURGERY;

EID: 41349092947     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.2.80     Document Type: Article

References (28)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
2. Chen D, Krasinski K, Sylvester A, Chen J, Nisen PD, Andrés V. Down regulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27 (KIP1), an inhibitor of neointima formation in the rat carotid artery. J Clin Invest 1997;99:2334-41.
3. Waltenberger J. Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation 1997;96:4083-94.
4. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation on human coronary arteries. Proc Natl Acad Sci USA 1990;87:4600-4.
5. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35-43.
6. Sriram V, Patterson C. Cell cycle in vasculoproliferative diseases: potential interventions and routes of delivery. Circulation 2001;103:2414-9.
7. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003;361:247-9.
8. Pearce BJ, McKinsey JF. Current status of intravascular stents as delivery devices to prevent restenosis. Vasc Endovasc Surg 2003;37:231-7.
9. Kataoka T, Honda Y, Bonneau HN, Yock PG, Fitzerald PJ. New catheter-based technology for the treatment of restenosis. J Interv Cardiol 2002;15:371-9.
10. Kim DW, Kwon JS, Kim YG, et al. Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model. Circulation 2004;109:1558-63.
11. Cho MC, Kwak NJ, Piao H, et al. Effect of paclitaxel local delivery on neointimal formation after endothelial denudation of the rat carotidartery Korean Cire J 2000;30:198-207.
12. Kwon JS, Park SS, Kim YG, et al. Perivascular delivery of paclitaxel with F-127 Pluronic gel inhibits neointimal hyperplasia in a rat carotid artery injury model. Korean Circ J 2005;35:221-7.
13. Kim DW, Kim YG, Oh TG, Cho MC, Kim ST. Retrovirus-mediated herpes simplex virus kinase gene therapy for the prevention of stenosis in rat carotid artery injury model. Korean Circ J 1998;28:shy; 977-89.
14. Cagiannos C, Abul-Khoudoud OR, DeRijk W, et al. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. J Vasc Surg 2005;42:980-8.
15. Gallo R, Padurean A, Jayaraman T, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999;99:2164-70.
16. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of rapamycin reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-93.
17. Pires NMM, van der Hoeven BL, de Vries MR, et al. Local perivascular delivery of anti-restenotic agents from a drug-eluting poly (εcombining macron below-caprolactone) stent cuff. Biomaterials 2005;26:5386-94.
18. Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 2005;111:926-31.
19. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-7.
20. Shafiq N, Malhotra S, Pandhi P, Grover A, Uboweja A. A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease. Br J Clin Pharmacol 2005;59:94-101.
21. Signore PE, Machan LS, Jackson JK, et al. Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J Vasc Interv Radiol 2001;12:79-88.
22. Schachner T, Zou Y, Oberhuber A, et al. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 2004;77:1580-5.
23. Hafizi S, Mordi VN, Andersson KM, Chester AH, Yacoub MH. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. Vascul Pharmacol 2004;41:167-76.
24. Rotmans JI, Pattynama PM, Verhagen HJ, et al. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation 2005;111:1537-42.
25. Hu Y, Zou Y, Dietrich H, Wick G, Xu Q. Inhibition of neointimal hyperplasia of mouse vein grafts by locally applied suramin. Circulation 1999;100:861-8.
26. Omura T, Yoshiyama M, Izumi Y, et al. Involvement of c-Jun NH2 terminal kinase and p38MAPK in rapamycin-mediated inhibition of neointimal formation in rat carotid arteries. J Cardiovasc Pharmacol 2005;46:519-25.
27. Scott NA, Cipolla GD, Ross CE, et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996;93:2178-87.
28. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-20.